Items tagged with Vaccines

Webinar: TB vaccines for adults and adolescents: Progress, prospect, and perspectives - recording now available online (post)

A webinar, organized by the Global Vaccine and Immunization Research Forum (GVIRF), brought together experts to discuss the status of TB vaccine development across the value chain, from articulation of the public health and economic need for new TB vaccines through the status and strategies for product development, to the considerations for approval, policy recommendation and use.

Latest TB research publications (post)

Breakthrough aerosol human infection model gives hope for future TB vaccine development (post)

University of Oxford researchers have for the first time established a controlled human infection model for tuberculosis (TB) that infects people via the lungs – the way TB enters the body.

TB vaccine workshop report published in Frontiers in Tuberculosis (post)

In October 2023, the Stop TB Partnership Working Group on New Vaccines (WGNV), IAVI, and the London School of Hygiene & Tropical Medicine co-hosted a workshop with tuberculosis (TB) high-burden country experts to build understanding of what epidemiological, impact, feasibility, and acceptability data would be needed to plan for TB vaccine introduction at the national level. With several TB vaccine candidates already in late-stage development, critical work is underway to understand what is needed for successful introduction of a new vaccine, especially within high-burden countries.

A century after the first TB vaccine, a new vaccine is reigniting hope (post)

Imagine a world where TB doesn’t steal millions of lives each year. That dream might be inching closer, thanks to a groundbreaking vaccine trial kicking off in South Africa.

7th Global Forum on TB Vaccines: Participant support available (post)

A limited amount of travel and registration support (participant support) is available for participants planning to attend the 7th Global Forum on TB Vaccines to be held on 8-10 October 2024 in Rio de Janiero, Brazil. Participant support is available for students, post-docs, early career researchers, advocates, affected communities, and participants from lower- and middle-income countries.

Researchers discover a potential vaccine to prevent TB in people of all ages (post)

In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach.

A new TB vaccine candidate recombinant protein with additional post-translational modifications occurring in Mycobacterium tuberculosis cells (post)

Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide. On the other hand, about one-fourth of the world's population carries Mycobacterium tuberculosis (M. tuberculosis) without showing any symptoms, and most of these carriers do not develop the disease.

Call for experts: WHO Technical Advisory Group on clinical and policy considerations for new TB vaccines (post)

The World Health Organization (WHO) is seeking experts to serve as members on WHO Technical Advisory Group on clinical and policy considerations for new TB vaccines.

TB Vax ARM webinar: Setting the scene for new TB vaccines (post)

The TB Vaccine Advocacy Roadmap (TB Vax ARM) will host a webinar on 16 July 2024 on the latest updates in the TB vaccine space.